Consistently in the xenograft model, a low dose of Ivabradine (1 mg/kg) or paclitaxel (2 mg/kg) alone, given twice weekly, did not affect tumour volume (Figure 7P) or did not affect the expression of HCN2 and HCN3 (Supporting information Figure S16). Here, HCN2 is linked to neoplasm.